REBISMART, the first electronic
injection device for the treatment
of multiple sclerosis, has been
approved for use in Australia and
will be available on the
Pharmaceutical Benefits Scheme
from 01 May.
The device includes an interactive
screen on the electronic injector
which guides patients through a
three step process with text and
pictures, to deliver a new multi-dose
presentation of Rebif (interferon
beta-1a).The above article was sent to subscribers in Pharmacy Daily's issue from 28 Apr 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Apr 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.